Cas no 118441-84-2 (Licoricesaponin G2)
Licoricesaponin G2 Chemical and Physical Properties
Names and Identifiers
-
- Licoricesaponin G2
- Glycyrrhiza Uralensis Fisch Polysaccharides
- Licorice saponin G2
- 3TOQ2I088A
- 24-Hydroxyglycyrrhizin
- UNII-3TOQ2I088A
- beta-D-Glucopyranosiduronic acid, (3beta,4beta,20beta)-20-carboxy-23-hydroxy-11-oxo-30-norolean-12-en-3-yl 2-o-beta-D-glucopyranuronosyl-
- (2S,3S,4S,5R,6R)-6-[(2R,3R,4S,5S,6S)-2-[[(3S,4S,4aR,6aR,6bS,8aS,11S,12aR,14aR,14bS)-11-carboxy-4-(hydroxymethyl)-4,6a,6b,8a,11,14b-hexamethyl-14-oxo-2,3,4a,5,6,7,8,9,10,12,12a,14a-dodecahydro-1H-picen-3-yl]oxy]-6-carboxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid
- CHEBI:184066
- Saponin G2, from licorice
- A-[[2-O-(6-oxo-
- E87119
- AKOS040760518
- A-D-glucopyranosyl)-6-oxo-
- CS-0101426
- 118441-84-2
- MS-31556
- 11-Oxo-3
- Licorice-saponin G2
- DTXSID101316120
- HY-N6983
- A-D-glucopyranosyl]oxy]-24-hydroxyolean-12-en-30-oic acid
- .BETA.-D-GLUCOPYRANOSIDURONIC ACID, (3.BETA.,4.BETA.,20.BETA.)-20-CARBOXY-23-HYDROXY-11-OXO-30-NOROLEAN-12-EN-3-YL 2-O-.BETA.-D-GLUCOPYRANURONOSYL-
- Q27258017
- 11-Oxo-3beta-[[2-O-(6-oxo-beta-D-glucopyranosyl)-6-oxo-beta-D-glucopyranosyl]oxy]-24-hydroxyolean-12-en-30-oic acid
- DA-75008
- CHEMBL5276551
- MSK160665
-
- Inchi: 1S/C42H62O17/c1-37-11-12-38(2,36(54)55)16-19(37)18-15-20(44)31-39(3)9-8-22(40(4,17-43)21(39)7-10-42(31,6)41(18,5)14-13-37)56-35-30(26(48)25(47)29(58-35)33(52)53)59-34-27(49)23(45)24(46)28(57-34)32(50)51/h15,19,21-31,34-35,43,45-49H,7-14,16-17H2,1-6H3,(H,50,51)(H,52,53)(H,54,55)/t19-,21+,22-,23-,24-,25-,26-,27+,28-,29-,30+,31+,34-,35+,37+,38-,39-,40+,41+,42+/m0/s1
- InChI Key: WBQVRPYEEYUEBQ-OJVDLISWSA-N
- SMILES: O([C@H]1[C@@H]([C@H]([C@@H]([C@@H](C(=O)O)O1)O)O)O[C@H]1[C@@H]([C@H]([C@@H]([C@@H](C(=O)O)O1)O)O)O)[C@H]1CC[C@@]2(C)[C@@H](CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@](C(=O)O)(C)C[C@H]5C4=CC([C@@H]32)=O)[C@@]1(C)CO
Computed Properties
- Exact Mass: 838.39870051g/mol
- Monoisotopic Mass: 838.39870051g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 9
- Hydrogen Bond Acceptor Count: 17
- Heavy Atom Count: 59
- Rotatable Bond Count: 8
- Complexity: 1750
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 20
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 2.5
- Topological Polar Surface Area: 287?2
Experimental Properties
- Color/Form: Powder
Licoricesaponin G2 Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| ChemFaces | CFN92915-10mg |
Licoricesaponin G2 |
118441-84-2 | >=98% | 10mg |
$218 | 2022-10-09 | |
| SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd. | L910837-5mg |
Licoricesaponin G2 |
118441-84-2 | 98% | 5mg |
¥4,649.40 | 2022-01-14 | |
| WU HAN AN JIE KAI Biomedical Technology Co., Ltd. | ajce57152-100mg |
Licoricesaponin G2 |
118441-84-2 | 98% | 100mg |
¥0.00 | 2023-09-07 | |
| WU HAN AN JIE KAI Biomedical Technology Co., Ltd. | ajce57152-250mg |
Licoricesaponin G2 |
118441-84-2 | 98% | 250mg |
¥0.00 | 2023-09-07 | |
| WU HAN AN JIE KAI Biomedical Technology Co., Ltd. | ajce57152-500mg |
Licoricesaponin G2 |
118441-84-2 | 98% | 500mg |
¥0.00 | 2023-09-07 | |
| MedChemExpress | HY-N6983-5mg |
Licoricesaponin G2 |
118441-84-2 | 98.72% | 5mg |
¥3400 | 2024-07-21 | |
| MedChemExpress | HY-N6983-10mg |
Licoricesaponin G2 |
118441-84-2 | 98.72% | 10mg |
¥4900 | 2024-07-21 | |
| TRC | L397720-1mg |
Licoricesaponin G2 |
118441-84-2 | 1mg |
$167.00 | 2023-05-18 | ||
| TRC | L397720-2.5mg |
Licoricesaponin G2 |
118441-84-2 | 2.5mg |
$362.00 | 2023-05-18 | ||
| TRC | L397720-5mg |
Licoricesaponin G2 |
118441-84-2 | 5mg |
$ 800.00 | 2023-09-07 |
Licoricesaponin G2 Suppliers
Licoricesaponin G2 Related Literature
-
Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
-
Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
-
J. Xu,T. J. Carrocci,A. A. Hoskins Chem. Commun., 2016,52, 549-552
-
Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
-
Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
Additional information on Licoricesaponin G2
Comprehensive Overview of Licoricesaponin G2 (CAS No. 118441-84-2): Properties, Applications, and Research Insights
Licoricesaponin G2 (CAS No. 118441-84-2) is a bioactive triterpenoid saponin derived from the roots of Glycyrrhiza species, commonly known as licorice. This compound has garnered significant attention in pharmaceutical and nutraceutical research due to its anti-inflammatory, antioxidant, and hepatoprotective properties. With the growing demand for natural therapeutics, Licoricesaponin G2 stands out as a promising candidate for addressing modern health challenges such as metabolic disorders and chronic inflammation.
The chemical structure of Licoricesaponin G2 features a glycone moiety attached to a triterpene aglycone, which is responsible for its bioactivity. Researchers have identified its potential in modulating NF-κB signaling pathways, a key target in inflammation-related diseases. Recent studies also highlight its role in skin care formulations, where it aids in reducing oxidative stress and improving epidermal barrier function—a hot topic in the cosmetic industry.
In the context of traditional Chinese medicine (TCM), licorice has been used for centuries, and Licoricesaponin G2 is one of its most studied active components. Modern applications extend to functional foods and dietary supplements, aligning with the global trend toward preventive healthcare. Consumers frequently search for terms like "natural anti-inflammatory agents" or "licorice root benefits," reflecting the compound's relevance in holistic wellness.
From a technical perspective, Licoricesaponin G2 is characterized by its high purity (>98% by HPLC) and solubility in polar solvents like methanol and DMSO. Its stability under physiological conditions makes it suitable for in vitro and in vivo studies. Analytical methods such as LC-MS and NMR spectroscopy are commonly employed for its quantification and structural verification.
The compound's safety profile is another area of interest. While licorice extracts are generally recognized as safe (GRAS), excessive intake of certain saponins may lead to pseudoaldosteronism. However, Licoricesaponin G2 is considered low-risk at therapeutic doses, making it a viable option for drug development. Current research explores its synergy with other phytochemicals to enhance efficacy while minimizing side effects.
Market trends indicate a rising demand for plant-derived actives, with Licoricesaponin G2 positioned as a key player in the nutraceutical and cosmeceutical sectors. Its multifunctionality—ranging from immune support to anti-aging—resonates with health-conscious consumers. For manufacturers, optimizing extraction techniques to improve yield without compromising bioactivity remains a critical focus.
In summary, Licoricesaponin G2 (CAS No. 118441-84-2) exemplifies the convergence of traditional knowledge and modern science. Its diverse applications, coupled with rigorous scientific validation, make it a compound of enduring significance in both academia and industry. Future research may further unlock its potential in addressing unmet medical needs, solidifying its place in the pantheon of natural therapeutics.
118441-84-2 (Licoricesaponin G2) Related Products
- 83896-44-0((3beta,18alpha)-30-hydroxy-11,30-dioxoolean-12-en-3-yl 2-O-beta-D-glucopyranuronosyl-alpha-D-glucopyranosiduronic acid)
- 103000-77-7(b-D-Glucopyranosiduronic acid, (3b,20b)-20-carboxy-11-oxo-30-norolean-12-en-3-yl 2-O-b-D-glucopyranuronosyl-)
- 121687-83-0(b-D-Glucopyranosiduronic acid, (3b,20b)-20-carboxy-11-oxo-30-norolean-12-en-3-yl 2-O-a-L-arabinopyranosyl- (9CI))
- 137476-70-1(b-D-Glucopyranosiduronic acid, (3b,20b)-20-carboxy-11-oxo-30-norolean-12-en-3-yl 4-O-b-D-glucopyranuronosyl- (9CI))
- 1002295-90-0(luteolin 7-O-beta-glucuronopyranosyl-(1->6)-O-beta-glucopyranoside)
- 119479-05-9(18beta-GA)
- 134250-15-0(β-D-Glucopyranosiduronic acid, (3β,20β)-29-hydroxy-11-oxoolean-12-en-3-yl 2-O-β-D-glucopyranuronosyl-)
- 1405-86-3(Glycyrrhizic acid)
- 34096-83-8(Glycyrrhetic acid 3-O-β-D-glucuronide)
- 105038-43-5(b-D-Glucopyranosiduronic acid, (3b,20b)-20-carboxy-11-oxo-30-norolean-12-en-3-yl 3-O-b-D-glucopyranuronosyl-)